top of page
Closing a Deal

clinician           partner
   Program

Eyerising Red-light Myopia Therapy Device

The Problem is that Myopia is a global pandemic. Also known as Nearsightedness, it is a visual condition where people can see close objects clearly, but objects farther away appear blurred. It is a progressive disease and the most common ocular disorder worldwide. It is the leading cause of visual impairment in children, and it's incidence is rapidly increasing. High Myopia is associated with significant increased risk for retinal degeneration and detachment, glaucoma, and cataracts at a young age.

ERP device.jfif

The Solution: Home use Red-light Myopia Therapy

*Just  3 minutes treatment 2x per day at home

*Only requires 5 days a week no requirements between treatment

*No drugs, no injections, no lenses

*high compliance levels

​

Certifications

  • ISO 13485 as the legal medical manufacturer for all regulatory approvals.

  • ANSI Safety Report-Group 1 lased device

  • CE mark as class IIa medical device

  • Medsafe NZ Class IIa Medical Device

  • MHRA approval as Class II medical device

  • TMMDA approval as Class IIa Medical device

  • TGA Approval as Class II a medical device

  • HSA, MDA, CDSCO submitted

  • FDA Pre-sub complete

Pre Qualifications for Clinician Partner

  • Must have obtained a certification for Myopia Management from any CPD Provider accredited by the PRC Board of Optometry

  • Must be a licensed Optometrist with valid PRC ID

  • Must Procure at least 1 Demo Device for clinic use

bottom of page